Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation

Eva Calvo-Pinilla(The Pirbright Institute), Javier Castillo‐Olivares(The Pirbright Institute)
Virus Research
December 12, 2013
10.1016/j.virusres.2013.12.002
Cited by 31

Related Papers

Recombinant vaccines against bluetongue virus
|Virus Research|2013|51
Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2
|PLoS ONE|2013|50
A protective bivalent vaccine against Rift Valley fever and bluetongue
|npj Vaccines|2020|35